Literature DB >> 26227157

Capsule Commentary on Margolis et al., A Successful Multifaceted Trial to Improve Hypertension Control in Primary Care: Why did it Work?

Azizi A Seixas1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26227157      PMCID： PMC4617920          DOI： 10.1007/s11606-015-3382-7

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

1.  A randomized controlled trial of positive-affect intervention and medication adherence in hypertensive African Americans.

Authors:  Gbenga O Ogedegbe; Carla Boutin-Foster; Martin T Wells; John P Allegrante; Alice M Isen; Jared B Jobe; Mary E Charlson
Journal:  Arch Intern Med       Date:  2012-01-23

2.  A Successful Multifaceted Trial to Improve Hypertension Control in Primary Care: Why Did it Work?

Authors:  Karen L Margolis; Stephen E Asche; Anna R Bergdall; Steven P Dehmer; Michael V Maciosek; Rachel A Nyboer; Patrick J O'Connor; Pamala A Pawloski; JoAnn M Sperl-Hillen; Nicole K Trower; Ann D Tucker; Beverly B Green
Journal:  J Gen Intern Med       Date:  2015-11       Impact factor: 5.128

3.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

Review 4.  Task shifting interventions for cardiovascular risk reduction in low-income and middle-income countries: a systematic review of randomised controlled trials.

Authors:  Gbenga Ogedegbe; Joyce Gyamfi; Jacob Plange-Rhule; Alisa Surkis; Diana Margot Rosenthal; Collins Airhihenbuwa; Juliet Iwelunmor; Richard Cooper
Journal:  BMJ Open       Date:  2014-10-16       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.